FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Lannett Company, Inc)

View source ↗

Summary

The FDA approved a supplemental application for Levothyroxine Sodium from Lannett Company, Inc, enabling the marketed generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hypothyroidism
• Goiter
• Hypothyroidism
• Thyroid Cancer

Drugs mentioned

• LEVOTHYROXINE SODIUM (levothyroxine sodium)

Snippet

SUPPL AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)